These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32470985)

  • 1. Presurgical Identification of Patients With Glioblastoma at Risk for Cognitive Impairment at 3-Month Follow-up.
    Rijnen SJM; Butterbrod E; Rutten GM; Sitskoorn MM; Gehring K
    Neurosurgery; 2020 Nov; 87(6):1119-1129. PubMed ID: 32470985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive outcomes in meningioma patients undergoing surgery: individual changes over time and predictors of late cognitive functioning.
    Rijnen SJM; Meskal I; Bakker M; De Baene W; Rutten GM; Gehring K; Sitskoorn MM
    Neuro Oncol; 2019 Jul; 21(7):911-922. PubMed ID: 30753679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Group Changes in Cognitive Performance After Surgery Mask Changes in Individual Patients with Glioblastoma.
    van Loenen IS; Rijnen SJM; Bruijn J; Rutten GM; Gehring K; Sitskoorn MM
    World Neurosurg; 2018 Sep; 117():e172-e179. PubMed ID: 29886297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary: Presurgical Identification of Patients With Glioblastoma at Risk for Cognitive Impairment at 3-Month Follow-up.
    Noll KR
    Neurosurgery; 2020 Nov; 87(6):E621-E622. PubMed ID: 32511696
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Presurgical Identification of Patients With Glioblastoma at Risk for Cognitive Impairment at 3-Month Follow-up.
    Rahman R; Rahman S; Ghani H; Lozada-Martinez ID; Al-Salihi MM; Rahman MM
    Neurosurgery; 2021 Oct; 89(5):E270-E271. PubMed ID: 34318895
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Presurgical Identification of Patients With Glioblastoma at Risk for Cognitive Impairment at 3-Month Follow-up.
    Della Pepa GM; Menna G; Quaranta D
    Neurosurgery; 2021 Sep; 89(4):E252. PubMed ID: 34318886
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Presurgical Identification of Patients With Glioblastoma at Risk for Cognitive Impairment at 3-Month Follow-up.
    Menna G; Caccavella VM; Olivi A; Della Pepa GM
    Neurosurgery; 2021 Apr; 88(5):E488. PubMed ID: 33611527
    [No Abstract]   [Full Text] [Related]  

  • 8. Preoperative thalamus volume is not associated with preoperative cognitive impairment (preCI) or postoperative cognitive dysfunction (POCD).
    Fislage M; Feinkohl I; Borchers F; Pischon T; Spies CD; Winterer G; Zacharias N;
    Sci Rep; 2023 Jul; 13(1):11732. PubMed ID: 37474784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive functioning in glioblastoma patients during radiotherapy and temozolomide treatment: initial findings.
    Hilverda K; Bosma I; Heimans JJ; Postma TJ; Peter Vandertop W; Slotman BJ; Buter J; Reijneveld JC; Klein M
    J Neurooncol; 2010 Mar; 97(1):89-94. PubMed ID: 19718545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of pre-existing cognitive impairment, amnesic mild cognitive impairment, and multiple domain mild cognitive impairment in men scheduled for coronary artery surgery.
    Hudetz JA; Patterson KM; Pagel PS
    Eur J Anaesthesiol; 2012 Jul; 29(7):320-5. PubMed ID: 22569024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cognition, schizophrenia and the effect of antipsychotics].
    Stip E
    Encephale; 2006; 32(3 Pt 1):341-50. PubMed ID: 16840928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment three months after surgery is an independent predictor of survival time in glioblastoma patients.
    Butterbrod E; Synhaeve N; Rutten GJ; Schwabe I; Gehring K; Sitskoorn M
    J Neurooncol; 2020 Aug; 149(1):103-111. PubMed ID: 32643066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjective cognitive functioning in patients with a meningioma: Its course and association with objective cognitive functioning and psychological symptoms.
    van Lonkhuizen PJC; Rijnen SJM; van der Linden SD; Rutten GM; Gehring K; Sitskoorn MM
    Psychooncology; 2019 Aug; 28(8):1654-1662. PubMed ID: 31141624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cognitive dysfunction in heart failure-Causes and sequelae].
    Wedegärtner SM; Böhm M; Kindermann I
    Internist (Berl); 2020 Sep; 61(9):929-938. PubMed ID: 32666209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Greater intraindividual variability in neuropsychological performance predicts cognitive impairment in de novo Parkinson's disease.
    Jones JD; Burroughs M; Apodaca M; Bunch J
    Neuropsychology; 2020 Jan; 34(1):24-30. PubMed ID: 31219297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive Impairment in Multiple Sclerosis: A Review of Neuropsychological Assessments.
    Korakas N; Tsolaki M
    Cogn Behav Neurol; 2016 Jun; 29(2):55-67. PubMed ID: 27336803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Domain-specific cognitive impairment in patients with COPD and control subjects.
    Cleutjens FA; Franssen FM; Spruit MA; Vanfleteren LE; Gijsen C; Dijkstra JB; Ponds RW; Wouters EF; Janssen DJ
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1-11. PubMed ID: 28031706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative cognitive dysfunction in patients with preoperative cognitive impairment: which domains are most vulnerable?
    Silverstein JH; Steinmetz J; Reichenberg A; Harvey PD; Rasmussen LS
    Anesthesiology; 2007 Mar; 106(3):431-5. PubMed ID: 17325500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests.
    Hoogland J; van Wanrooij LL; Boel JA; Goldman JG; Stebbins GT; Dalrymple-Alford JC; Marras C; Adler CH; Junque C; Pedersen KF; Mollenhauer B; Zabetian CP; Eslinger PJ; Lewis SJG; Wu RM; Klein M; Rodriguez-Oroz MC; Cammisuli DM; Barone P; Biundo R; de Bie RMA; Schmand BA; Tröster AI; Burn DJ; Litvan I; Filoteo JV; Geurtsen GJ; Weintraub D;
    Mov Disord; 2018 Nov; 33(11):1750-1759. PubMed ID: 30216541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.